Oral Antimetabolite After Surgery Associated With Survival Benefit in Biliary Tract Cancer
January 26th 2022Patients with biliary tract cancer achieved a better survival outcome after receiving treatment with an oral antimetabolite following surgical resection than patients who only were treated with surgery.